RedHill Biopharma reported $4.48M in Selling and Administration Expenses for its fiscal quarter ending in March of 2024.





Selling And Administration Expenses Change Date
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.33M 50K Sep/2025
Cronos Group USD 14.56M 1.33M Sep/2025
RedHill Biopharma USD 4.48M 1.52M Mar/2024